Clinical Study of A Single-Center Clinical Study to Evaluate the Safety and Biodistribution of Technetium Tc 99m Ec20 in Normal Volunteers and Ovarian Cancer Patients.

Trial Profile

Clinical Study of A Single-Center Clinical Study to Evaluate the Safety and Biodistribution of Technetium Tc 99m Ec20 in Normal Volunteers and Ovarian Cancer Patients.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Apr 2015

At a glance

  • Drugs Technetium Tc99m etarfolatide (Primary)
  • Indications Ovarian cancer
  • Focus Pharmacokinetics
  • Sponsors Endocyte
  • Most Recent Events

    • 27 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top